Range of suitable clients: CDEC discussed the uncertainty in the amount of people with reasonably intense to extreme hemophilia B in Canada qualified for etranacogene dezaparvovec. Medical specialists consulted by CADTH indicated that some sufferers that are categorized as obtaining delicate or reasonable condition could possibly have a critical bl